Christopher is Director of Cell Therapy R&D at Fresenius Kabi USA, where he leads a multi disciplinary team in developing next-generation cell processing technologies. With over 13 years at Fresenius and a background in biomedical engineering, he has pioneered innovations in closed-system cell washing, cryopreservation, and membrane separation. A named inventor on several patents and an author of peer-reviewed publications, Christopher combines technical leadership with deep expertise in device design for cell and gene therapies.

‍